Switch theme
Sign up to access all valuation multiples
Procter & Gamble Hygiene and Health Care Ltd is an Indian company engaged in the manufacturing and selling of feminine hygiene care and healthcare products. The portfolio includes brands like Ambi Pur, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide Ariel, Duracell, Gillette, Vicks, and Wella. The business is divided into a feminine hygiene business and a healthcare business. The feminine hygiene business offers sanitary napkins and feminine sanitary hygiene products; its popular brand is Whisper. The healthcare business offers creams, cough drops, and other health products. The company distributes its products through various channels: from retail locations such as mass merchandizers and grocery stores, to drug stores and department stores.
1964
439
LTM Revenue $504M
LTM EBITDA $120M
$5.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Procter & Gamble Hygiene has a last 12-month revenue (LTM) of $504M and a last 12-month EBITDA of $120M.
In the most recent fiscal year, Procter & Gamble Hygiene achieved revenue of $491M and an EBITDA of $120M.
Procter & Gamble Hygiene expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Procter & Gamble Hygiene valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $504M | XXX | $491M | XXX | XXX | XXX |
| Gross Profit | $315M | XXX | $275M | XXX | XXX | XXX |
| Gross Margin | 62% | XXX | 56% | XXX | XXX | XXX |
| EBITDA | $120M | XXX | $120M | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| EBIT | $113M | XXX | $111M | XXX | XXX | XXX |
| EBIT Margin | 22% | XXX | 23% | XXX | XXX | XXX |
| Net Profit | $85.6M | XXX | $79.1M | XXX | XXX | XXX |
| Net Margin | 17% | XXX | 16% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Procter & Gamble Hygiene's stock price is INR 13584 (or $159).
Procter & Gamble Hygiene has current market cap of INR 441B (or $5.2B), and EV of INR 436B (or $5.1B).
See Procter & Gamble Hygiene trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5.1B | $5.2B | XXX | XXX | XXX | XXX | $2.73 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Procter & Gamble Hygiene has market cap of $5.2B and EV of $5.1B.
Procter & Gamble Hygiene's trades at 10.6x EV/Revenue multiple, and 43.8x EV/EBITDA.
Equity research analysts estimate Procter & Gamble Hygiene's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Procter & Gamble Hygiene has a P/E ratio of 60.3x.
See valuation multiples for Procter & Gamble Hygiene and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5.2B | XXX | $5.2B | XXX | XXX | XXX |
| EV (current) | $5.1B | XXX | $5.1B | XXX | XXX | XXX |
| EV/Revenue | 10.1x | XXX | 10.6x | XXX | XXX | XXX |
| EV/EBITDA | 42.6x | XXX | 43.8x | XXX | XXX | XXX |
| EV/EBIT | 45.3x | XXX | 47.5x | XXX | XXX | XXX |
| EV/Gross Profit | 16.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 60.3x | XXX | 65.2x | XXX | XXX | XXX |
| EV/FCF | 75.1x | XXX | 84.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialProcter & Gamble Hygiene's last 12 month revenue growth is 13%
Procter & Gamble Hygiene's revenue per employee in the last FY averaged $1.1M, while opex per employee averaged $0.4M for the same period.
Procter & Gamble Hygiene's rule of 40 is 37% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Procter & Gamble Hygiene's rule of X is 57% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Procter & Gamble Hygiene and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| EBITDA Growth | 22% | XXX | 16% | XXX | XXX | XXX |
| Rule of 40 | 37% | XXX | 37% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 57% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 15% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Procter & Gamble Hygiene acquired XXX companies to date.
Last acquisition by Procter & Gamble Hygiene was XXXXXXXX, XXXXX XXXXX XXXXXX . Procter & Gamble Hygiene acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Procter & Gamble Hygiene founded? | Procter & Gamble Hygiene was founded in 1964. |
| Where is Procter & Gamble Hygiene headquartered? | Procter & Gamble Hygiene is headquartered in India. |
| How many employees does Procter & Gamble Hygiene have? | As of today, Procter & Gamble Hygiene has 439 employees. |
| Is Procter & Gamble Hygiene publicy listed? | Yes, Procter & Gamble Hygiene is a public company listed on NSE. |
| What is the stock symbol of Procter & Gamble Hygiene? | Procter & Gamble Hygiene trades under PGHH ticker. |
| When did Procter & Gamble Hygiene go public? | Procter & Gamble Hygiene went public in 2004. |
| Who are competitors of Procter & Gamble Hygiene? | Similar companies to Procter & Gamble Hygiene include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Procter & Gamble Hygiene? | Procter & Gamble Hygiene's current market cap is $5.2B |
| What is the current revenue of Procter & Gamble Hygiene? | Procter & Gamble Hygiene's last 12 months revenue is $504M. |
| What is the current revenue growth of Procter & Gamble Hygiene? | Procter & Gamble Hygiene revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Procter & Gamble Hygiene? | Current revenue multiple of Procter & Gamble Hygiene is 10.1x. |
| Is Procter & Gamble Hygiene profitable? | Yes, Procter & Gamble Hygiene is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Procter & Gamble Hygiene? | Procter & Gamble Hygiene's last 12 months EBITDA is $120M. |
| What is Procter & Gamble Hygiene's EBITDA margin? | Procter & Gamble Hygiene's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of Procter & Gamble Hygiene? | Current EBITDA multiple of Procter & Gamble Hygiene is 42.6x. |
| What is the current FCF of Procter & Gamble Hygiene? | Procter & Gamble Hygiene's last 12 months FCF is $68.0M. |
| What is Procter & Gamble Hygiene's FCF margin? | Procter & Gamble Hygiene's last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of Procter & Gamble Hygiene? | Current FCF multiple of Procter & Gamble Hygiene is 75.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
